Jeffrey Skinner
Geen lopende functies
Vermogen: 175 269 $ op 31-03-2024
Profiel
Jeffrey Skinner worked as the Director of Business Development at SteriMax, Inc. from 2012 to 2014.
He then worked as the Vice President of Business Development at ChitogenX, Inc. After that, he worked as the Vice President of Business Development at Valeo Pharma, Inc. from 2014 to 2023.
Mr. Skinner received his undergraduate degree and MBA from the University of Western Ontario in 1997 and 1999, respectively.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
1.42% | 15-03-2023 | 1 402 150 ( 1.42% ) | 175 269 $ | 31-03-2024 |
Eerdere bekende functies van Jeffrey Skinner
| Bedrijven | Functie | Einde |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01-07-2023 |
SteriMax, Inc.
 SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Corporate Officer/Principal | 01-07-2014 |
| CHITOGENX INC. | Corporate Officer/Principal | - |
Opleiding van Jeffrey Skinner
| University of Western Ontario | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHITOGENX INC. | Health Technology |
| VALEO PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Health Technology |
